Back to Journals » Neuropsychiatric Disease and Treatment » Volume 7 » Issue 1

Exploration of sex differences in Rhes effects in dopamine mediated behaviors

Authors Quintero G, Spano

Published 17 November 2011 Volume 2011:7(1) Pages 697—706

DOI https://doi.org/10.2147/NDT.S25888

Review by Single-blind

Peer reviewer comments 3

Gabriel C Quintero1,2, Daniela Spano3
1INDICASAT AIP, Centro de Neurociencias, Panamá, 2Department of Psychology, University of New Orleans, N Orleans, Louisiana, USA; 3CEINGE Biotechnologie Avanzate, Naples, Italy

Abstract: Studies have shown that Ras homolog enriched in striatum (Rhes) proteins are highly expressed in areas of the central nervous system that have high dopaminergic innervation. In this study, we used Rhes mutant mice (Wild type, Rhes KO, Rhes Heterozygous) of both sexes to explore differences in the effects of Rhes protein levels in basal levels of activity, anxiety, and stereotypy, in relation to sex. Adult male and female mice were evaluated in an open field test for measuring basal levels of activity and anxiety for 5 consecutive days, and they were tested in the apomorphine-induced stereotypy paradigm. Rhes protein levels affected basal levels of activity but it was not found to be related to sex differences. Moreover, a decrease in Rhes protein levels was linked to a nonsignificant anxiolytic effect, mainly in female mice. Finally, a decrease in Rhes protein levels does not affect dopamine D1 and D2 receptor (D1/D2) synergism in female or male mice. Together, these results suggest that Rhes protein levels affect locomotion activity, and have an influence in anxiety depending on sex; Rhes protein levels do not affect D1/D2 synergism in both sexes.

Keywords: behavior, dopamine receptor, Rhes protein, mutant mice, sexes

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]